STALICLA’s Post

View organization page for STALICLA, graphic

4,800 followers

Delighted to have published our study on the identification of the first autism subgroup and matching treatment! Full manuscript available: https://lnkd.in/dZ8Xn2RD #Stalicla #Neurology #Innovation #Biotechnology #CNS #precisionmedicine #NDD #neuropsychiatry

  • No alternative text description for this image
Neomar Semprún-Hernández

Biólogo Inmunólogo | Fundador de BioTherapy | CEO de la UINM

3mo

It is important to understand the endophenotypes present and observed in autism and provide a more appropriate and respectful explanation beyond a diagnosis based on behaviors. This is wonderful. Greetings from Zurich.

Micah Sickel

MD, PHD, FAPA | Dual-trained Psychiatrist/Neuroscientist | USPHS Veteran | 14 years in Public-Health/Government/Military Health System | Consultant to mid-size CRO and small-size biotech | CNS & Psychedelics

3mo

Congratulations! Were you able to analyze for SYNGAP1 mutations?

Like
Reply
Alexander Niculescu, MD, PhD

Professor of Psychiatry and Medical Neuroscience at Indiana University School of Medicine

3mo

Keep up the good work Lynn!

Like
Reply
Purnanand Sarma

Serial Biotech Executive/Entrepreneur/Investor. President-TiE Boston, Chairman, Stalicla, SA, Consulting CEO GelMEDIX. Ex President &CEO and Board member of Immunome (NASDAQ:IMNM) and TARIS Biomedical

2mo

Congratulations !

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics